000			01378 a2200361 4500
005			20250513064353.0
264		0	_c19940629
008			199406s 0 0 eng d
022			_a0014-5793
024	7		_a10.1016/0014-5793(94)00424-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aCleeter, M W
245	0	0	_aReversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. _h[electronic resource]
260			_bFEBS letters _cMay 1994
300			_a50-4 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aElectron Transport _xdrug effects
650	0	4	_aElectron Transport Complex IV _xantagonists & inhibitors
650	0	4	_aGlutathione _xanalogs & derivatives
650	0	4	_aMitochondria, Muscle _xdrug effects
650	0	4	_aNitric Oxide _xpharmacology
650	0	4	_aNitroso Compounds _xpharmacology
650	0	4	_aParkinson Disease _xmetabolism
650	0	4	_aRats
650	0	4	_aS-Nitrosoglutathione
700	1		_aCooper, J M
700	1		_aDarley-Usmar, V M
700	1		_aMoncada, S
700	1		_aSchapira, A H
773	0		_tFEBS letters _gvol. 345 _gno. 1 _gp. 50-4
856	4	0	_uhttps://doi.org/10.1016/0014-5793(94)00424-2 _zAvailable from publisher's website
999			_c8193914 _d8193914